Landmarks ThermaVein® expands global network

08 Aug 2013

Landmark Investments Group, the Bolton-based investment firm, has agreed terms for the exclusive distribution of its ThermaVein® product in the Middle East, Holland, Australia and New Zealand, with a combined minimum contract value of £7.4million.

Landmark Investments Group, the Bolton-based investment firm, has agreed terms for the exclusive distribution of its ThermaVein® product in the Middle East, Holland, Australia and New Zealand, with a combined minimum contract value of £7.4million.

Landmark acquired worldwide rights for the medically-acclaimed treatment to remove facial veins in 2012. The business announced an £8.6million exclusive distribution rights deal with Tekno-Surgical (part of the SISK Group) in the UK and Ireland earlier this year and is on track to expand its global network over the next 12 months.Distribution rights have been agreed with global company, Medistat International, for the Middle East - including Lebanon, Kuwait, Libya and UAE, as well as in Holland – over a five-year contract. SSA has been selected to distribute ThermaVein® in Australia and New Zealand, also over a five year contract.

Jonathan Cresswell, sales manager at SSA, commented, “We are delighted to be adding ThermaVein® to our growing aesthetics division. We expect ThermaVein® to be very successful in the Australian market where our culture and climate has created a growing demand for skin treatment technology.”

Mark Hawthorn, managing director of Landmark Investments Group, added, “Working with established and experienced global partners is bringing about rapid expansion of its sales network and allowing us to invest in new product ranges to meet the growing demand for skin treatments across several continents.”

Landmark is in detailed discussions with a number of US and Far Eastern organisations and expects to announce further distribution agreements in the next few months.

Comments

Log-in to post a comment